1. Home
  2. OP vs CHEK Comparison

OP vs CHEK Comparison

Compare OP & CHEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OP
  • CHEK
  • Stock Information
  • Founded
  • OP 2021
  • CHEK 2004
  • Country
  • OP Greece
  • CHEK Israel
  • Employees
  • OP N/A
  • CHEK N/A
  • Industry
  • OP
  • CHEK Medical Electronics
  • Sector
  • OP
  • CHEK Health Care
  • Exchange
  • OP Nasdaq
  • CHEK Nasdaq
  • Market Cap
  • OP 8.5M
  • CHEK 9.0M
  • IPO Year
  • OP N/A
  • CHEK 2015
  • Fundamental
  • Price
  • OP $1.12
  • CHEK $0.93
  • Analyst Decision
  • OP
  • CHEK
  • Analyst Count
  • OP 0
  • CHEK 0
  • Target Price
  • OP N/A
  • CHEK N/A
  • AVG Volume (30 Days)
  • OP 11.5K
  • CHEK 78.9K
  • Earning Date
  • OP 12-20-2024
  • CHEK 02-18-2025
  • Dividend Yield
  • OP N/A
  • CHEK N/A
  • EPS Growth
  • OP N/A
  • CHEK N/A
  • EPS
  • OP N/A
  • CHEK N/A
  • Revenue
  • OP $25,729,000.00
  • CHEK N/A
  • Revenue This Year
  • OP N/A
  • CHEK N/A
  • Revenue Next Year
  • OP N/A
  • CHEK N/A
  • P/E Ratio
  • OP N/A
  • CHEK N/A
  • Revenue Growth
  • OP 36.33
  • CHEK N/A
  • 52 Week Low
  • OP $1.02
  • CHEK $0.56
  • 52 Week High
  • OP $3.15
  • CHEK $3.45
  • Technical
  • Relative Strength Index (RSI)
  • OP 40.22
  • CHEK 42.16
  • Support Level
  • OP $1.11
  • CHEK $0.81
  • Resistance Level
  • OP $1.24
  • CHEK $1.00
  • Average True Range (ATR)
  • OP 0.05
  • CHEK 0.10
  • MACD
  • OP -0.00
  • CHEK -0.05
  • Stochastic Oscillator
  • OP 7.17
  • CHEK 13.98

About OP OceanPal Inc.

OceanPal Inc is a provider of shipping transportation services. It specializes in the ownership of vessels. Each of its vessels is owned through a separate wholly-owned subsidiary.

About CHEK Check-Cap Ltd.

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.

Share on Social Networks: